医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2015年
13期
28-28,29
,共2页
许秀春%艾志勇%樊兴海%杨欢欢
許秀春%艾誌勇%樊興海%楊歡歡
허수춘%애지용%번흥해%양환환
留置胃管%下呼吸道感染%细菌%耐药性
留置胃管%下呼吸道感染%細菌%耐藥性
류치위관%하호흡도감염%세균%내약성
Indwelling gastric tube%The lower respiratory tract infection%Bacteria%Drug resistance
目的:研究留置胃管患者院内下呼吸道感染病原体的构成及耐药情况。方法:对2012年6月至2014年5月我院各科收治的135例留置胃管患者下呼吸道感染病原体分布及耐药情况进行回顾性分析。结果:共检出187株,其中革兰阴性杆菌145株(77.5%),革兰阳性菌37株(19.7%),真菌5株(2.6%)。药敏结果提示鲍曼不动杆菌、铜绿假单胞菌等出现多重高比例的耐药。结论:留置胃管患者院内下呼吸道感染病原体以革兰阴性杆菌为主,存在多重耐药,临床应重视病原学培养鉴定,合理选用抗生素。
目的:研究留置胃管患者院內下呼吸道感染病原體的構成及耐藥情況。方法:對2012年6月至2014年5月我院各科收治的135例留置胃管患者下呼吸道感染病原體分佈及耐藥情況進行迴顧性分析。結果:共檢齣187株,其中革蘭陰性桿菌145株(77.5%),革蘭暘性菌37株(19.7%),真菌5株(2.6%)。藥敏結果提示鮑曼不動桿菌、銅綠假單胞菌等齣現多重高比例的耐藥。結論:留置胃管患者院內下呼吸道感染病原體以革蘭陰性桿菌為主,存在多重耐藥,臨床應重視病原學培養鑒定,閤理選用抗生素。
목적:연구류치위관환자원내하호흡도감염병원체적구성급내약정황。방법:대2012년6월지2014년5월아원각과수치적135례류치위관환자하호흡도감염병원체분포급내약정황진행회고성분석。결과:공검출187주,기중혁란음성간균145주(77.5%),혁란양성균37주(19.7%),진균5주(2.6%)。약민결과제시포만불동간균、동록가단포균등출현다중고비례적내약。결론:류치위관환자원내하호흡도감염병원체이혁란음성간균위주,존재다중내약,림상응중시병원학배양감정,합리선용항생소。
ObjectiveTo study the patients with indwelling gastric tube form of nosocomial lower respiratory tract infection pathogens and drug resistance.Methods From June 2012 to May 2014, 135 cases were in all the subjects in our indwelling gastric tube in patients with lower respiratory tract infection pathogens distribution and drug resistance were retrospectively analyzed.Results A total of 187 strains of gram-negative bacilli 145 strains (77.5%), gram positive bacteria 37 strains (19.7%), fungus 5 strains (2.6%). Drug susceptibilityresults suggest acinetobacter baumannii, pseudomonas aeruginosa bacteria such as polychronic high rates of drug resistance.ConclusionIndwelling gastric tube in patients with nosocomial lower respiratory tract infection pathogens is given priority to with gram-negative bacilli, there are multiple drug resistance and clinical should pay attention to the culture identification of pathogeny, reasonable choice of antibiotics.